August 20 SessionThis month, the selected study sheds new light on the packaging and replication of SARS-CoV-2 virus as potential targets for new therapies. Our presenter and panelists with their diverse expertise will take us to an in-depth discussion of the findings and explore their potential treatment implications.
Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate.
Christiane Iserman, Christine Roden, Mark Boerneke, Rachel Sealfon, Grace McLaughlin, Irwin Jungreis, Chris Park, Avinash Boppana, Ethan Fritch, Yixuan J. Hou, Chandra Theesfeld, Olga G Troyanskaya, Ralph S. Baric, Timothy P. Sheahan, Kevin Weeks, Amy S. Gladfelter. bioRxiv 2020.06.11.147199; doi: https://doi.org/10.1101/2020.06.11.147199
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Matthew Weitzman, Ph.D.
Children's Hospital of Philadelphia
Lynn W. Enquist, Ph.D.
Next Session Date: Sept. 17, 2020 (registration will open Sept. 1)
Missed a past club session? Recordings are available free to ASM members.View the Journal Club Archives